However, in diabetes, local VEGFA expression becomes dysregulated, as rodent models of diabetic nephropathy show elevated renal VEGFA, and pharmacological blockade of VEGF signaling in these models reduces albuminuria and glomerular injury [21,22]. Here, VEGFA is linked to diabetic kidney disease.